Literature DB >> 16513106

Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.

Marize C Valadares1, Aline L Ramos, Franz-Josef K Rehmann, Nigel J Sweeney, Katja Strohfeldt, Matthias Tacke, Mary L S Queiroz.   

Abstract

The effects of a new titanocene compound with an ansa ligand in the cyclopentadienyl rings, the 1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride (TITANOCENE X), on the growth and differentiation of granulocyte-macrophage progenitor cells [colony-forming unit-granulocyte-macrophage (CFU-GM)] and Natural killer (NK) cell activity in Ehrlich's ascites tumour (EAT)-bearing mice were studied. Myelosuppression concomitant with increased numbers of spleen CFU-GM was observed in tumour-bearing mice. Treatment of these animals with TITANOCENE X (2.5-50 mg/kg/day) produced an increase in myelopoiesis, in a dose-dependent manner, and reduced spleen colony formation. In addition, the treatment of EAT-bearing mice with 3 doses of 20 or 50 mg/kg TITANOCENE X restored to normal values the reduced Natural killer cell function observed during tumour growth. In parallel, TITANOCENE X prolonged, in a dose-dependent manner, the survival of mice inoculated with Ehrlich's ascites tumour. The highest dose of 50 mg/kg prolonged in 50% the survival time of EAT-bearing mice, compared to non-treated tumour-bearing controls. In comparison with previous results from our laboratory addressing the effects of titanocenes on haematopoiesis, we observed with TITANOCENE X a similar effective profile as for bis(cyclopentadienyl) dithiocyanate titanium(IV), being both less effective than di(cyclopentadienyl) dichloro titanium(IV), since the latter not only prolonged, but also increased the rate of survival. These differences in efficacy may be due to the nature of the ansa-cyclopentadienyl ligand used in TITANOCENE X, since the C2 bridge between the two cyclopentadienyl groups will increase the hydrolytic stability by an organometallic chelate effect. Also, the introduction of two dimethylamino substituents increases the water solubility of TITANOCENE X when compared to titanocene dichloride itself.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513106     DOI: 10.1016/j.ejphar.2006.01.056

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Titanium(IV) complexes: cytotoxicity and cellular uptake of titanium(IV) complexes on caco-2 cell line.

Authors:  Ramón Hernández; Janet Méndez; José Lamboy; Madeline Torres; Féliz R Román; Enrique Meléndez
Journal:  Toxicol In Vitro       Date:  2009-09-20       Impact factor: 3.500

2.  Structure-activity studies of Ti(IV) complexes: aqueous stability and cytotoxic properties in colon cancer HT-29 cells.

Authors:  Ramón Hernández; José Lamboy; Li Ming Gao; Jaime Matta; Félix R Román; Enrique Meléndez
Journal:  J Biol Inorg Chem       Date:  2008-02-21       Impact factor: 3.358

3.  Water-soluble molybdenocene complexes with both proliferative and antiproliferative effects on cancer cell lines and their binding interactions with human serum albumin.

Authors:  Idainés Feliciano; Jaime Matta; Enrique Meléndez
Journal:  J Biol Inorg Chem       Date:  2009-06-18       Impact factor: 3.358

4.  Synthesis, Ti(IV) intake by apotransferrin and cytotoxic properties of functionalized titanocene dichlorides.

Authors:  Li Ming Gao; Ramón Hernández; Jaime Matta; Enrique Meléndez
Journal:  J Biol Inorg Chem       Date:  2007-06-14       Impact factor: 3.358

5.  Dimethylamino-functionalised and N-heteroaryl-substituted titanocene anticancer drugs: synthesis and cytotoxicity studies.

Authors:  Thomas Hickey; James Claffey; Eoin Fitzpatrick; Megan Hogan; Clara Pampillón; Matthias Tacke
Journal:  Invest New Drugs       Date:  2007-05-22       Impact factor: 3.850

6.  Synthesis and cytotoxicity studies of titanocene C analogues.

Authors:  Megan Hogan; James Claffey; Eoin Fitzpatrick; Thomas Hickey; Clara Pampillón; Matthias Tacke
Journal:  Met Based Drugs       Date:  2008

7.  Substituted titanocenes induce caspase-dependent apoptosis in human epidermoid carcinoma cells in vitro and exhibit antitumour activity in vivo.

Authors:  J H Bannon; I Fichtner; A O'Neill; C Pampillón; N J Sweeney; K Strohfeldt; R W Watson; M Tacke; M M Mc Gee
Journal:  Br J Cancer       Date:  2007-10-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.